The Cost-Effectiveness Of Hepatitis B Vaccination Using Heplisav Versus Engerix-B In Select Adult Populations In The United States
May 1, 2013, 00:00
10.1016/j.jval.2013.03.427
https://www.valueinhealthjournal.com/article/S1098-3015(13)00498-1/fulltext
Title :
The Cost-Effectiveness Of Hepatitis B Vaccination Using Heplisav Versus Engerix-B In Select Adult Populations In The United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00498-1&doi=10.1016/j.jval.2013.03.427
First page :
A92
Section Title :
Infection
Open access? :
No
Section Order :
1474